ZenaTech unit ZenaDrone begins building mobile operations trailer for multi-drone farm jobs
Bitget2026/10/08 12:30ZenaTech’s ZenaDrone started building a mobile operations trailer to automate multi-drone precision agriculture jobs under its Drone as a Service model. Prototype trailer targets up to five IQ Octo drones with automated battery recharging, payload refilling, autonomous launch, landing. Testing is scheduled for the coming months; production is expected at ZenaTech’s Mesa, Arizona facility. Design aims to raise daily capacity, cut downtime, lower operating costs; future adaptations planned for surveying, inspection services. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenatech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080830OMX_____CNEWS_EN_GNW9841985_en) on October 08, 2026, and is solely responsible for the information contained therein.
- ZenaTech’s ZenaDrone started building a mobile operations trailer to automate multi-drone precision agriculture jobs under its Drone as a Service model.
- Prototype trailer targets up to five IQ Octo drones with automated battery recharging, payload refilling, autonomous launch, landing.
- Testing is scheduled for the coming months; production is expected at ZenaTech’s Mesa, Arizona facility.
- Design aims to raise daily capacity, cut downtime, lower operating costs; future adaptations planned for surveying, inspection services.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
